MREO - Mereo BioPharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.814B

Cash

48.66M

Avg Qtr Burn

-4.969M

Short % of Float

0.68%

Insider Ownership

0.55%

Institutional Own.

58.08%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Setrusumab (UX143) Details Osteogenesis imperfecta	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Alvelestat (MPH-966) (oral neutrophil elastase inhibitor) Details Bronchiolitis Obliterans Syndrome	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Alvelestat (MPH-966) (oral neutrophil elastase inhibitor) Details Severe alpha-1 antitrypsin deficiency, Lung disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Etigilimab Details Ovarian cancer, Cancer	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Etigilimab (MPH-313) (Antibody against TIGIT) + Nivolumab Details Solid tumor/s, Cancer	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Alvelestat (MPH-966) (oral neutrophil elastase inhibitor) Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.